NDC 59528-0331 - Calphron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59528-0331
- Package NDCs from labels
- 59528-0331-2
- Manufacturer
- Nephro-Tech, Inc. | Nexgen Pharma
- Effective date
- 2016-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Calphron - Nephro-Tech, Inc. | Nexgen Pharma | Nephro-Tech, Inc. | Nexgen Pharma | 2016-05-12 | DIETARY SUPPLEMENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59528-0331-2 | Calphron | 200 in 1 BOTTLE, PLASTIC | TABLET | 200 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59528-0331 | CALPHRON (MINERAL SUPPLEMENT CONTAINING CALCIUM ACETATE) TABLET [NEPHRO-TECH, INC.] | 5 | 1 package rows | 20160513_86f2e3d2-dbe3-400b-91cf-a4bf41db1342.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59528-0331-2 | EA - Each | 59528-0331 | aa16e9b9-11cf-43c3-83de-3d74372f755c | 1 | 2014-08-01 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CALCIUM ACETATE | ACTIVE INGREDIENT | Y882YXF34X | CALPHRON (MINERAL SUPPLEMENT CONTAINING CALCIUM ACETATE) TABLET [NEPHRO-TECH, INC.] | 2 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | CALPHRON (MINERAL SUPPLEMENT CONTAINING CALCIUM ACETATE) TABLET [NEPHRO-TECH, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CALCIUM ACETATE | CALCIUM ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ac4975aa-0ee9-4473-81e2-839f1556e684 | 2023-07-28 | Warnings, Adverse reactions | 197433 Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | SQUARE PHARMACEUTICALS LIMITED | 5af79d16-31ad-4d68-9a6d-bb5d9c91535d | 2023-07-03 | Warnings, Adverse reactions | Y882YXF34X |
| Calcarea Acetica | CALCAREA ACETICA | Hahnemann Laboratories, INC. | df3828ff-cd21-97ca-e053-2a95a90a9c8a | 2022-05-17 | Y882YXF34X | |
| Calcium Acetate | CALCIUM ACETATE | Cipla USA Inc., | 000c044a-12ef-4484-942e-99552b777d58 | 2021-06-01 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | EXELAN PHARMACEUTICALS, INC. | a5725f95-621e-425b-946d-434b3fec24eb | 2021-06-01 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Amneal Pharmaceuticals of New York LLC | 4a490e1d-80ee-461f-aba6-01f54fe8a5fe | 2020-07-31 | Warnings, Adverse reactions | Y882YXF34X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.